HISOAR(SZ:002099)2022-12-08 08:46Group 1: Company Overview - The company is Zhejiang Haixiang Pharmaceutical Co., Ltd., with stock code 002099 [1] - The meeting took place on September 14, 2015, at Taizhou Liting Phoenix Mountain Villa [1] Group 2: Dye Products - Recent price trends for dye products show that the price of Reactive Blue has been stable with slight fluctuations [2] - The KN-R project has a designed capacity of 8,000 tons, which is currently fully operational, while the second phase is under construction and expected to be completed next year [2] - The company is a market leader in KN-R, holding a significant market share and being a drafter of national and industry standards [2] Group 3: Future Development Plans - The company plans to expand its product range by introducing over ten new products, including reactive and acid dyes, to reduce reliance on a single product for revenue [2] - New projects are backed by feasibility studies, ensuring that sales can absorb the increased production capacity [3] Group 4: Pharmaceutical Sector - The pharmaceutical segment has seen resource integration and refined management, resulting in a year-on-year gross margin increase of 2.7% [3] - Breakthroughs in formulation and custom processing businesses have significantly improved profitability, with Haikuo Biological expected to achieve a reduction in losses by the end of the year [3]